Re: Chen S, Shi M, Shen L, et al. Microwave ablation versus sorafenib for intermediate-stage hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. Int J hyperthermia 2020
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | International Journal of Hyperthermia |
Online Access: | http://dx.doi.org/10.1080/02656736.2020.1847331 |
id |
doaj-b83676470f3d448093cc6b7c6d36de0c |
---|---|
record_format |
Article |
spelling |
doaj-b83676470f3d448093cc6b7c6d36de0c2021-08-09T15:50:03ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572020-01-013711312131210.1080/02656736.2020.18473311847331Re: Chen S, Shi M, Shen L, et al. Microwave ablation versus sorafenib for intermediate-stage hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. Int J hyperthermia 2020Zhaonan Li0Xinwei Han1Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Interventional Radiology, The First Affiliated Hospital of Zhengzhou Universityhttp://dx.doi.org/10.1080/02656736.2020.1847331 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Zhaonan Li Xinwei Han |
spellingShingle |
Zhaonan Li Xinwei Han Re: Chen S, Shi M, Shen L, et al. Microwave ablation versus sorafenib for intermediate-stage hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. Int J hyperthermia 2020 International Journal of Hyperthermia |
author_facet |
Zhaonan Li Xinwei Han |
author_sort |
Zhaonan Li |
title |
Re: Chen S, Shi M, Shen L, et al. Microwave ablation versus sorafenib for intermediate-stage hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. Int J hyperthermia 2020 |
title_short |
Re: Chen S, Shi M, Shen L, et al. Microwave ablation versus sorafenib for intermediate-stage hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. Int J hyperthermia 2020 |
title_full |
Re: Chen S, Shi M, Shen L, et al. Microwave ablation versus sorafenib for intermediate-stage hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. Int J hyperthermia 2020 |
title_fullStr |
Re: Chen S, Shi M, Shen L, et al. Microwave ablation versus sorafenib for intermediate-stage hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. Int J hyperthermia 2020 |
title_full_unstemmed |
Re: Chen S, Shi M, Shen L, et al. Microwave ablation versus sorafenib for intermediate-stage hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. Int J hyperthermia 2020 |
title_sort |
re: chen s, shi m, shen l, et al. microwave ablation versus sorafenib for intermediate-stage hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. int j hyperthermia 2020 |
publisher |
Taylor & Francis Group |
series |
International Journal of Hyperthermia |
issn |
0265-6736 1464-5157 |
publishDate |
2020-01-01 |
url |
http://dx.doi.org/10.1080/02656736.2020.1847331 |
work_keys_str_mv |
AT zhaonanli rechensshimshenletalmicrowaveablationversussorafenibforintermediatestagehepatocellularcarcinomawithtranscatheterarterialchemoembolizationrefractorinessapropensityscorematchinganalysisintjhyperthermia2020 AT xinweihan rechensshimshenletalmicrowaveablationversussorafenibforintermediatestagehepatocellularcarcinomawithtranscatheterarterialchemoembolizationrefractorinessapropensityscorematchinganalysisintjhyperthermia2020 |
_version_ |
1721213806201274368 |